3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
143
Colorectal Neoplasms
97
Carcinoma, Non-Small-Cell Lung
97
Carcinoma, Hepatocellular
69
Stomach Neoplasms
65
Rectal Neoplasms
54
Neoplasms
53
Lung Neoplasms
45
Colonic Neoplasms
41
Nasopharyngeal Carcinoma
39
Leukemia, Myeloid, Acute
39
Prostatic Neoplasms
38
Lymphoma, Large B-Cell, Diffuse
38
Uterine Cervical Neoplasms
36
Neoplasm Metastasis
33
Ovarian Neoplasms
32
Esophageal Neoplasms
32
Multiple Myeloma
31
Lymphoma
31
Lymphoma, Follicular
30
Leukemia
28
Pancreatic Neoplasms
27
Recurrence
22
Head and Neck Neoplasms
22
Brain Neoplasms
21
Urinary Bladder Neoplasms
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Lymphoma, Non-Hodgkin
19
Squamous Cell Carcinoma of Head and Neck
17
Lymphoma, Mantle-Cell
17
Interventions
sintilimab
1
nedaplatin
1
Pemetrexed
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Unknown
×
Advanced Non-squamous Non-Small-Cell Lung Cancer
×
Clear all
NCT05648071
2022-12-13
SPBPDC
Qianfoshan Hospital
Phase 3
Unknown
60 enrolled